Jayme Maniatis has 16 years of healthcare communications experience and has been with Schwartz Communications since 1997. As a vice president, Maniatis counsels her clients on strategy and messaging. Maniatis has helped to develop, manage and execute varied PR and social media campaigns, including those designed to support clinical trial recruitment, market conditioning, regulatory events, product launches, corporate communications, mature brand revitalization, scientific milestones and issue awareness.
As a member of the healthcare practice, Maniatis has worked with a diverse group of clients, specializing in diagnostic and therapeutic medical devices, pharmaceuticals, biotech and healthcare IT. During her tenure at Schwartz, she has represented clients ranging from market challenger to market leader, including Boston Scientific, Bioness Inc. Cyberonics, Haemonetics, StemCells, Inc., Sanarus Medical, PerkinElmer Life Sciences, and Phase Forward. Maniatis currently manages strategic PR programs for units within GE Healthcare's $17 billion business.
Maniatis helped lead one of Schwartz’s most successful medical device campaigns on behalf of Philips Medical System. The multi-year campaign raised awareness of sudden cardiac arrest and the need for public defibrillators. As part of the campaign, Maniatis helped to plan, manage and execute the launch of the first home defibrillator, followed by the first over-the-counter clearance of a therapeutic medical device. Maniatis also managed a non-branded consumer awareness initiative in the area of obstructive sleep apnea on behalf of ResMed and Philips Respironics. This award-winning campaign exceeded its goals by helping to increase the diagnosis rate in communities nationwide.
Maniatis’ teams have won many of the PR industry’s most prestigious national and regional awards, including the Communicator Crystal Awards, Silver SABRE Award, PRSA Bronze Anvil and numerous Bell Ringer Awards from the New England Publicity Club.
She regularly engages top-tier media to secure feature coverage for her clients. Maniatis has successfully placed strategic stories in influential media outlets such as The Wall Street Journal, USA Today, The New York Times, the Associated Press, Forbes, ABC “World News Tonight,” CBS “Evening News,” CNN and “Good Morning America.”
Prior to joining Schwartz, Maniatis was a corporate communications representative at Repligen Corporation, a Massachusetts-based biotech company, where she focused on both media and investor relations activities. She also did work for a boutique healthcare communications agency based in Cambridge, Mass.
Maniatis graduated from the University of Massachusetts Amherst with a B.A. in communications.